NEXT day delivery available - 3pm cut off
Worldwide shipping available
Free standard UK delivery on orders over £100
This article is written for qualified aesthetic practitioners and prescribers. It is educational content, not advice for members of the public.
Mesotherapy for face treatments are simple to describe and easy to get wrong. The idea is to deliver small volumes of a dilute, non-cross-linked or lightly cross-linked solution into the superficial and mid dermis, in many points, over a short course. The patient then sees a gradual change in hydration, texture and luminosity rather than a structural change. Whether that happens depends far more on three planning decisions than on any single product: which indication you are treating, which layer you are placing the product into, and how you schedule the course.
Below we break down how experienced injectors approach facial mesotherapy in practice, from product selection and needle choice to technique, session spacing, patient selection and record keeping.
For a practitioner, the useful definition is narrow. Facial mesotherapy is the intradermal or very superficial subdermal injection of small aliquots of a solution, usually containing free hyaluronic acid alongside vitamins, amino acids, minerals, antioxidants or peptides, with the aim of improving skin quality. It is not volumisation and it is not contouring. If a patient needs projection or structural support, that conversation belongs to filler or collagen stimulators, and mixing up the two is one of the most common reasons patients come away disappointed.
The term also gets used loosely for skin boosters and bioremodelling products. There is real overlap in technique, but the distinction matters when you plan. A classic mesotherapy cocktail is typically low viscosity, injected in many small deposits or a fine nappage pattern, and repeated over several sessions. A higher-concentration hyaluronic acid skin booster is often injected in fewer, slightly larger boluses with fewer sessions. Knowing which category your chosen product sits in tells you how to inject it.
Start from the skin concern, then match the formulation. Reading the manufacturer's instructions for use is not optional: concentration, recommended depth, volume per session and treatment interval vary between products, and the IFU is what your protocol and insurance will be measured against.
This is the indication most patients present with. Polyrevitalising formulations that combine free HA with a broad mix of vitamins, amino acids, coenzymes and minerals are the usual choice. Fillmed NCTF 135HA is a well-known example of this category, and the Revitacare Cytocare 532 sits in a similar space with a higher HA concentration than the entry-level Cytocare products.
For patients with crepey texture and fine static lines, practitioners tend to choose a formulation with a higher HA content or one with peptide components, and to concentrate passes on the lower face, perioral area and cheeks. Be honest in consultation about what superficial treatment can achieve here: deeper folds and volume loss need a different plan.
Brightening and clarifying cocktails exist for pigmentation and oily, congested skin. They work best as part of a wider plan that includes home care and sun protection, and they should not be promoted as a fix for melasma or active acne. Patients with active inflammatory acne, infection or open lesions in the treatment area should be deferred.
Under eye mesotherapy is popular, but the skin is thin, the vascular network is dense and bruising is common. Use only products whose IFU covers periocular use, inject very superficially, use small volumes and avoid the area altogether in patients with significant festoons, malar oedema or a history of fluid retention. Some practitioners prefer a dedicated periorbital booster or polynucleotide for this area instead; our earlier piece on polynucleotides under the eyes covers that decision in more depth.
You can browse the full range of solutions in the Filler World mesotherapy collection, which includes face, scalp and body formulations. Check the indication on each product page before ordering for facial use.
Most facial mesotherapy is delivered into the dermis at shallow depth. Placing product too deep reduces its effect on surface texture and wastes volume; placing it too superficially in one spot can leave visible papules that take longer to settle. A short, fine needle helps control this. 30G to 32G needles of 4mm length are common for facial work, and longer 13mm needles are used for linear threading in some techniques. For a detailed sizing breakdown, see our article on mesotherapy needle sizes, and you can find stock in the needles, cannulas and syringes collection.
Whichever technique you use, map the treatment zones before you start, keep a steady entry angle and track volume per area so you can repeat or adjust at the next session. Many practitioners record this on a simple face chart in the notes.
No, and the difference matters for consent and product choice. Microneedling creates controlled channels across the skin surface, and any product applied topically afterwards must be suitable for that use. Mesotherapy places a measured volume of an injectable product into the dermis. Some clinics combine the two in one appointment, but products should only be used in the way their IFU allows; an injectable solution is not automatically approved for topical application over microchannels, and topical serums are not designed for injection.
Mesotherapy is a course-based treatment. Most manufacturers recommend an initial series of several sessions spaced a few weeks apart, followed by maintenance sessions. Exact intervals and the number of sessions vary by product, so plan the course from the IFU rather than from habit.
Practical points that help with outcomes and retention:
Good outcomes start with saying no to the wrong patient. Typical exclusions and reasons to defer include pregnancy and breastfeeding, active skin infection or inflammation in the area, known allergy to any component of the product, autoimmune disease in an active phase, a history of keloid or hypertrophic scarring, and patients on anticoagulant or antiplatelet therapy where bruising risk needs discussion with their prescriber. Always check the product-specific contraindications in the IFU, as some formulations list additional exclusions.
Also screen expectations. Mesotherapy improves skin quality gradually. It does not lift, and it does not replace volume. Write the agreed goals into the consultation notes.
Facial mesotherapy is minimally invasive, but the documentation standard should be the same as for any injectable. Your consent process should cover the expected course, common reactions such as redness, swelling, small bumps and bruising, rarer risks such as infection and hypersensitivity, and the fact that results vary between patients.
For each session, record the product name, batch or lot number and expiry date, the volume used per area, needle size and technique, and any immediate reactions. Keeping batch numbers on file means you can respond quickly if a manufacturer issues a field safety notice. Store products according to the manufacturer's temperature guidance and check expiry dates before each treatment, particularly with multi-vial boxes that may be opened across several weeks of bookings.
Aftercare is simple but worth giving in writing. Typical advice includes avoiding make-up for the rest of the day, avoiding saunas, steam rooms and strenuous exercise for 24 hours, not touching or massaging the area, and using daily sun protection. Tell patients what is normal (small bumps and redness that settle within a day or so, possible bruising) and what is not (increasing pain, spreading redness, heat or discharge), and give them a clear route to contact the clinic.
Both aim to improve skin quality with superficial injections. Mesotherapy usually uses lower-viscosity cocktails of HA with vitamins, amino acids and other actives in many small deposits over a course of sessions. Skin boosters often use higher HA concentrations with fewer injection points and fewer sessions. Always follow the specific product's IFU.
Most protocols use an initial course of several sessions a few weeks apart, then maintenance treatments. The exact schedule depends on the product and the indication, so build your plan around the manufacturer's recommendations and the patient's response.
Common contraindications include pregnancy and breastfeeding, active infection or inflammation in the treatment area, allergy to any ingredient, a history of keloid scarring and certain autoimmune conditions. Patients on blood-thinning medication need an individual risk discussion. Product IFUs may list further exclusions.
No. Microneedling creates microchannels across the skin surface, while mesotherapy injects a measured volume of product into the dermis. They can be combined, but only with products whose instructions permit that use.
Yes, with products indicated for the periorbital area, very superficial placement and small volumes. Bruising is more common here, and patients with significant oedema or festoons are usually better served by a different approach.
Mesotherapy for face rewards careful planning more than speed. Match the formulation to the indication, keep placement in the dermis with a fine, short needle, book a proper course, and document every session with batch numbers and volumes. Set realistic expectations at consultation and the treatment becomes a dependable skin-quality option alongside the rest of your injectable menu.
